Table 4.
NLR and PLR of serum annexin A1 for differentiating lung cancer patients from normal people | ||||
| ||||
Interval | Positive | Negative | Likelihood ratio | 95% CI |
| ||||
1-2 | 0 | 25 | 0.000 | 0.000 to 0.312 |
2-3 | 0 | 60 | 0.000 | 0.000 to 0.128 |
3-4 | 0 | 55 | 0.000 | 0.000 to 0.140 |
4-5 | 41 | 101 | 0.388 | 0.282 to 0.534 |
5-6 | 156 | 15 | 9.934 | 6.017 to 16.402 |
6-7 | 71 | 0 | ∞ | 8.446 to ∞ |
Total | 268 | 256 | ||
| ||||
NLR and PLR of serum annexin A1 for differentiating lung cancer patients from benign lung disease patient | ||||
| ||||
---|---|---|---|---|
Interval | Positive | Negative | Likelihood ratio | 95% CI |
| ||||
1.5-2.0 | 0 | 6 | 0.000 | 0.000 to 1.494 |
2.0-2.5 | 0 | 17 | 0.000 | 0.000 to 0.400 |
2.5-3.0 | 0 | 16 | 0.000 | 0.000 to 0.426 |
3.0-3.5 | 0 | 36 | 0.000 | 0.000 to 0.185 |
3.5-4.0 | 0 | 27 | 0.000 | 0.000 to 0.248 |
4.0-4.5 | 0 | 20 | 0.000 | 0.000 to 0.338 |
4.5-5.0 | 41 | 35 | 0.962 | 0.635 to 1.455 |
5.0-5.5 | 76 | 53 | 1.177 | 0.870 to 1.592 |
5.5-6.0 | 80 | 7 | 9.382 | 4.424 to 19.894 |
6.0-6.5 | 71 | 4 | 14.571 | 5.407 to 39.265 |
Total | 268 | 221 |
NLR, negative likelihood ratio; PLR, positive likelihood ratio; 95% CI, 95% confidence interval.